Zymeworks, Inc. (ZYME)
28.27
-0.74
(-2.55%)
USD |
NASDAQ |
Aug 28, 16:00
27.87
-0.40
(-1.41%)
After-Hours: 20:00
Zymeworks Free Cash Flow : -120.53M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -120.53M |
| March 31, 2026 | -77.62M |
| December 31, 2025 | -35.43M |
| September 30, 2025 | -64.46M |
| June 30, 2025 | -39.19M |
| March 31, 2025 | -76.14M |
| December 31, 2024 | -110.72M |
| September 30, 2024 | -57.14M |
| June 30, 2024 | -94.13M |
| March 31, 2024 | -76.02M |
| December 31, 2023 | -121.27M |
| September 30, 2023 | 182.49M |
| June 30, 2023 | 152.71M |
| March 31, 2023 | 102.14M |
| December 31, 2022 | 125.60M |
| September 30, 2022 | -247.71M |
| June 30, 2022 | -227.73M |
| March 31, 2022 | -223.23M |
| Date | Value |
|---|---|
| December 31, 2021 | -204.61M |
| September 30, 2021 | -201.02M |
| June 30, 2021 | -168.66M |
| March 31, 2021 | -165.36M |
| December 31, 2020 | -162.29M |
| September 30, 2020 | -148.83M |
| June 30, 2020 | -149.05M |
| March 31, 2020 | -113.33M |
| December 31, 2019 | -96.23M |
| September 30, 2019 | -8.609M |
| June 30, 2019 | -2.007M |
| March 31, 2019 | 16.78M |
| December 31, 2018 | 20.37M |
| September 30, 2018 | 11.78M |
| June 30, 2018 | 11.37M |
| March 31, 2018 | -7.086M |
| December 31, 2017 | -2.963M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Theravance Biopharma, Inc. | 53.73M |
| BridgeBio Pharma, Inc. | -437.79M |
| Aprea Therapeutics, Inc. | -12.31M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.59M |
| Cash from Investing (Quarterly) | 16.67M |
| Cash from Financing (Quarterly) | -50.62M |
| Free Cash Flow Per Share (Quarterly) | -0.4327 |
| Free Cash Flow to Equity (Quarterly) | -36.68M |
| Free Cash Flow to Firm (Quarterly) | -25.03M |
| Free Cash Flow Yield | -5.71% |